Argentinean consensus guidelines on the use of monoclonal antibodies in patients with migraine

Migraine is a very prevalent disorder that is estimated to affect about 15% of adult subjects. Recently, the efficacy and safety of monoclonal antibodies that act on the calcitonin gene-related peptide pathway (MA-CGRP) has been evaluated in migraine. Several groups around the world have developed c...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Revista de neurologiá 2020-02, Vol.70 (4), p.149-158
Hauptverfasser:	Doctorovich, E D, Martín-Bertuzzi, F, Goicochea, M T, Miranda, S, Figuerola, M L, Schubaroff, P A, Buonanotte, F, Rocchi, V, Rua, I, Bruera, O C, Giglio, J, De Paz, J J, Pelli-Noble, R, Arago, L, Burgos, M, Ayala, L S, Davidow, L, Bonamico, L
Format:	Artikel
Sprache:	spa
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!